Volume 3, Issue 4 (November 2024)
Health Science Monitor 2024, 3(4): 348-357 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mohammadi R, Rostamzadeh A, Khadem Vatan K, Yekta Z. Investigation of the frequency of causes of atrial fibrillation in hospitalized patients diagnosed with AF in the heart department of Taleghani Hospital in Urmia. Health Science Monitor 2024; 3 (4) :348-357
URL: http://hsm.umsu.ac.ir/article-1-196-en.html
URL: http://hsm.umsu.ac.ir/article-1-196-en.html
Associate Professor, Department of Cardiology, Urmia University of Medical Sciences, Urmia, Iran
Abstract: (623 Views)
Background & Aims: Atrial fibrillation (AF) is one of the most common cardiac arrhythmias and is classified as tachyarrhythmias. The purpose is to establish a correct and accurate patient diagnosis based on priorities and control, and to give importance to the timely and complete treatment of the disease, as well as the control and treatment of AF and related diseases as a leading factor in preventing heart failure.
Materials & Methods: In this cross-sectional descriptive study, 300 patients diagnosed with AF and hospitalized in the cardiac department of Taleghani Hospital between 2003 and 2004 were included. Ultimately, the collected data were analyzed using SPSS version 12 software.
Results: The average age of the patients in this study was 62.66 ± 11.2 years. Of the 300 AF patients studied, 162 (54%) were female and 138 (46%) were male. Among the patients, 95 (31%) had heart failure, of whom 31 (32.63%) had HTN, 27 (28.42%) had IHD, 9 (9.47%) had VHD, 4 (4.21%) had CMP, 2 (2.1%) had COPD, and 1 (1.05%) had thyrotoxicosis.
Conclusion: According to this study's findings, several areas should be considered for these patients, including diagnosis, disease control, identifying the background of the disease, preventing complications, and ensuring regular follow-up.
Materials & Methods: In this cross-sectional descriptive study, 300 patients diagnosed with AF and hospitalized in the cardiac department of Taleghani Hospital between 2003 and 2004 were included. Ultimately, the collected data were analyzed using SPSS version 12 software.
Results: The average age of the patients in this study was 62.66 ± 11.2 years. Of the 300 AF patients studied, 162 (54%) were female and 138 (46%) were male. Among the patients, 95 (31%) had heart failure, of whom 31 (32.63%) had HTN, 27 (28.42%) had IHD, 9 (9.47%) had VHD, 4 (4.21%) had CMP, 2 (2.1%) had COPD, and 1 (1.05%) had thyrotoxicosis.
Conclusion: According to this study's findings, several areas should be considered for these patients, including diagnosis, disease control, identifying the background of the disease, preventing complications, and ensuring regular follow-up.
Type of Study: Research |
Subject:
General
Received: 2024/09/6 | Accepted: 2024/11/4 | Published: 2024/11/20
Received: 2024/09/6 | Accepted: 2024/11/4 | Published: 2024/11/20
References
1. Potpara TS, Lip GY. Lone atrial fibrillation: what is known and what is to come. International journal of clinical practice. 2011;65(4):446-57. [DOI] [PMID]
2. Hatamabadi HR, Amini A, Alimohammadi H, Sabzghabaie A, Lashkari A. The process of atrial fibrillation treatment in hospitals in Iran. Razi Journal of Medical Sciences. 2014;21(126):43-54. [URL]
3. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen S-A, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012;14(4):528-606. [DOI] [PMID]
4. Xu J, Huang Y, Cai H, Qi Y, Jia N, Shen W, et al. Is cryoballoon ablation preferable to radiofrequency ablation for treatment of atrial fibrillation by pulmonary vein isolation? A meta-analysis. PloS one. 2014;9(2):e90323. [DOI] [PMID] [PMCID]
5. Kim YG, Choi YY, Han K-D, Min K, Choi HY, Shim J, et al. Atrial fibrillation is associated with increased risk of lethal ventricular arrhythmias. Scientific reports. 2021;11(1):18111. [DOI] [PMID] [PMCID]
6. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-47. [DOI] [PMID] [PMCID]
7. Colilla S, Crow A, Petkun W, Singer DE, Simon T, Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the US adult population. The American journal of cardiology. 2013;112(8):1142-7. [DOI] [PMID]
8. Friberg J, Buch P, Scharling H, Gadsbøll N, Jensen GB. Rising rates of hospital admissions for atrial fibrillation. Epidemiology. 2003;14(6):666-72. [DOI] [PMID]
9. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. The Lancet. 2015;386(9989):154-62. [DOI] [PMID]
10. Fordyce CB, Roe MT, Ahmad T, Libby P, Borer JS, Hiatt WR, et al. Cardiovascular drug development: is it dead or just hibernating? Journal of the American College of Cardiology. 2015;65(15):1567-82. [DOI] [PMID]
11. Braunwald E. Cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. New England Journal of Medicine. 1997;337(19):1360-9. [DOI] [PMID]
12. Benjamin EJ, Chen P-S, Bild DE, Mascette AM, Albert CM, Alonso A, et al. Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop. Circulation. 2009;119(4):606-18. [DOI] [PMID] [PMCID]
13. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56-e528. [DOI]
14. Lloyd-Jones DM, Wang TJ, Leip EP, Larson MG, Levy D, Vasan RS, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110(9):1042-6. [DOI] [PMID]
15. Mou L, Norby FL, Chen LY, O'Neal WT, Lewis TT, Loehr LR, et al. Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC study (Atherosclerosis Risk in Communities). Circulation: Arrhythmia and Electrophysiology. 2018;11(7):e006350. [DOI] [PMID] [PMCID]
16. Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European :union:, from 2000 to 2060. European heart journal. 2013;34(35):2746-51. [DOI] [PMID] [PMCID]
17. Di Carlo A, Bellino L, Consoli D, Mori F, Zaninelli A, Baldereschi M, et al. Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European :union:: the FAI Project. Ep Europace. 2019;21(10):1468-75. [DOI] [PMID]
18. Chiang C-E, Wang K-L, Lip GY. Stroke prevention in atrial fibrillation: an Asian perspective. Thrombosis and haemostasis. 2014;112(05):789-97. [DOI] [PMID]
19. Essien UR, Kornej J, Johnson AE, Schulson LB, Benjamin EJ, Magnani JW. Social determinants of atrial fibrillation. Nature Reviews Cardiology. 2021;18(11):763-73. [DOI] [PMID] [PMCID]
20. Habibzadeh F, Yadollahie M, Roshanipoor M, Haghighi AB. Prevalence of atrial fibrillation in a primary health care centre in Fars Province, Islamic Republic of Iran. EMHJ-Eastern Mediterranean Health Journal, 10 (1-2), 147-151, 2004. 2004. [DOI] [PMID]
21. Platonov PG, Corino VD. A clinical perspective on atrial fibrillation. Atrial Fibrillation from an Engineering Perspective. 2018:1-24. [DOI]
22. Cotter PE, Martin PJ, Ring L, Warburton EA, Belham M, Pugh PJ. Incidence of atrial fibrillation detected by implantable loop recorders in unexplained stroke. Neurology. 2013;80(17):1546-50. [DOI] [PMID] [PMCID]
23. Dilaveris PE, Kennedy HL. Silent atrial fibrillation: epidemiology, diagnosis, and clinical impact. Clinical cardiology. 2017;40(6):413-8. [DOI] [PMID] []
24. Aronow WS, Banach M. Atrial fibrillation: the new epidemic of the ageing world. Journal of atrial fibrillation. 2009;1(6). [DOI] [PMID] [PMCID]
25. Morseth B, Geelhoed B, Linneberg A, Johansson L, Kuulasmaa K, Salomaa V, et al. Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium. Open Heart. 2021;8(2):e001624. [DOI] [PMID] [PMCID]
26. Levy S. Atrial fibrillation, the arrhythmia of the elderly, causes and associated conditions. Anadolu Kardiyol Derg. 2002;2(1):55-60. [Google Scholar]
27. Lévy S. Factors predisposing to the development of atrial fibrillation. Pacing and clinical electrophysiology. 1997;20(10):2670-4. [DOI] [PMID]
28. Staerk L, Sherer JA, Ko D, Benjamin EJ, Helm RH. Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes. Circulation research. 2017;120(9):1501-17. [DOI] [PMID] [PMCID]
29. Rosman L, Lampert R, Ramsey CM, Dziura J, Chui PW, Brandt C, et al. Posttraumatic stress disorder and risk for early incident atrial fibrillation: a prospective cohort study of 1.1 million young adults. Journal of the American Heart Association. 2019;8(19):e013741. [DOI] [PMID] [PMCID]
30. Zubaid M, Rashed WA, Alsheikh-Ali AA, AlMahmeed W, Shehab A, Sulaiman K, et al. Gulf survey of atrial fibrillation events (Gulf SAFE) design and baseline characteristics of patients with atrial fibrillation in the arab middle East. Circulation: Cardiovascular Quality and Outcomes. 2011;4(4):477-82. [DOI] [PMID]
31. Wilke T, Groth A, Mueller S, Pfannkuche M, Verheyen F, Linder R, et al. Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. Europace. 2013;15(4):486-93. [DOI] [PMID]
32. Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clinical epidemiology. 2014:213-20. [DOI] [PMID] [PMCID]
33. Le Heuzey J-Y, Breithardt G, Camm J, Crijns H, Dorian P, Kowey PR, et al. The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation. The American journal of cardiology. 2010;105(5):687-93. [DOI] [PMID]
34. Vermond RA, Geelhoed B, Verweij N, Tieleman RG, Van der Harst P, Hillege HL, et al. Incidence of atrial fibrillation and relationship with cardiovascular events, heart failure, and mortality: a community-based study from the Netherlands. Journal of the American College of Cardiology. 2015;66(9):1000-7. [DOI] [PMID]
35. Wańkowicz P, Nowacki P, Gołąb-Janowska M. Atrial fibrillation risk factors in patients with ischemic stroke. Archives of Medical Science: AMS. 2021;17(1):19. [DOI] [PMID] []
36. Krisai P, Johnson LS, Moschovitis G, Benz A, Ramasundarahettige C, McIntyre WF, et al. Incidence and predictors of heart failure in patients with atrial fibrillation. CJC open. 2021;3(12):1482-9. [DOI] [PMID] []
37. Schnabel RB, Rienstra M, Sullivan LM, Sun JX, Moser CB, Levy D, et al. Risk assessment for incident heart failure in individuals with atrial fibrillation. European journal of heart failure. 2013;15(8):843-9. [DOI] [PMID] [PMCID]
38. Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BHC, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. European heart journal. 2006;27(8):949-53. [DOI] [PMID]
39. Michelena HI, Powell BD, Brady PA, Friedman PA, Ezekowitz MD. Gender in atrial fibrillation: ten years later. Gender medicine. 2010;7(3):206-17. [DOI] [PMID]
40. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Archives of internal medicine. 1995;155(5):469-73. [DOI] [PMID]
41. Oldgren J, Healey JS, Ezekowitz M, Commerford P, Avezum A, Pais P, et al. Variations in cause and management of atrial fibrillation in a prospective registry of 15 400 emergency department patients in 46 countries: The RE-LY atrial fibrillation registry. Circulation. 2014;129(15):1568-76. [DOI] [PMID]
42. Naser N, Dilic M, Durak A, Kulic M, Pepic E, Smajic E, et al. The impact of risk factors and comorbidities on the incidence of atrial fibrillation. Materia socio-medica. 2017;29(4):231. [DOI] [PMID] []
43. O'Neal WT, Soliman EZ, Qureshi W, Alonso A, Heckbert SR, Herrington D. Sustained pre-hypertensive blood pressure and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis. Journal of the American Society of Hypertension. 2015;9(3):191-6. [DOI] [PMID] [PMCID]
44. Naser N, Dzubur A, Durak A, Kulic M, Naser N. Blood pressure control in hypertensive patients, cardiovascular risk profile and the prevalence of masked uncontrolled hypertension (MUCH). Medical Archives. 2016;70(4):274. [DOI] [PMID] [PMCID]
45. Oori MJ, Mohammadi F, Norozi K, Fallahi-Khoshknab M, Ebadi A, Gheshlagh RG. Prevalence of HTN in Iran: meta-analysis of published studies in 2004-2018. Current hypertension reviews. 2019;15(2):113-22. [DOI] [PMID] [PMCID]
46. Esteghamati A, Abbasi M, Alikhani S, Gouya MM, Delavari A, Shishehbor MH, et al. Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran. American journal of hypertension. 2008;21(6):620-6. [DOI] [PMID]
47. Oori MJ, Mohammadi F, Norouzi-Tabrizi K, Fallahi-Khoshknab M, Ebadi A. Prevalence of medication adherence in patients with hypertension in Iran: A systematic review and meta-analysis of studies published in 2000-2018. Arya Atherosclerosis. 2019;15(2):82. [DOI] [PMID] [PMCID]
48. Liang F, Wang Y. Coronary heart disease and atrial fibrillation: a vicious cycle. American Journal of Physiology-Heart and Circulatory Physiology. 2021;320(1):H1-H12. [DOI] [PMID]
49. Shah V, Desai T, Agrawal A. The association between chronic obstructive pulmonary disease (COPD) and atrial fibrillation: A review. Chron Obstruct Pulmon Dis. 2016;1(2). [DOI]
50. Goudis CA. Chronic obstructive pulmonary disease and atrial fibrillation: an unknown relationship. Journal of cardiology. 2017;69(5):699-705. [DOI] [PMID]
51. Esteghamati A, Etemad K, Koohpayehzadeh J, Abbasi M, Meysamie A, Noshad S, et al. Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005-2011. Diabetes research and clinical practice. 2014;103(2):319-27. [DOI] [PMID]
52. Esteghamati A, Larijani B, Aghajani MH, Ghaemi F, Kermanchi J, Shahrami A, et al. Diabetes in Iran: prospective analysis from first nationwide diabetes report of National Program for Prevention and Control of Diabetes (NPPCD-2016). Scientific reports. 2017;7(1):13461. [DOI] [PMID] [PMCID]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
